1-(PHENYLBUTHYL)-3-BENZYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | EutJ9AifcH |
|---|---|
| InChI | InChI=1S/C24H24N2O3S/c27-24-22-16-7-8-17-23(22)25(18-10-9-13-20-11-3-1-4-12-20)30(28,29)26(24)19-21-14-5-2-6-15-21/h1-8,11-12,14-17H,9-10,13,18-19H2 |
| InChIKey | MTVHXAFRBRQPBM-UHFFFAOYSA-N |
| Mol Weight | 420.53 g/mol |
| Molecular Formula | C24H24N2O3S |
| Exact Mass | 420.150764 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-[(4-CHLOROPHENYL)METHYL]-3-CYCLOHEXYLMETHYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
1-[(4-CHLOROPHENYL)METHYL]-3-PROPYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
1-[(3,4-DICHLOROPHENYL)MEHYL]-3ETHYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
1-BENZYL-3-ISOPROPYL-1H-2,1,3-BENZOTHIADIAZIN-(4)-3H-ONE 2,2-DIOXIDE
1-(4-NITROBENZYL)-3-ISOPROPYL-1H-2,1,3-BENZOTHIADIAZIN-(4)-3H-ONE 2,2-DIOXIDE
1-[(4-CHLOROPHENYL)METHYL]-3-ISOPROYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
1H-2,1,3-Benzothiadiazin-4(3H)-one, 8-methoxy-1-methyl-3-(1-methylethyl)-, 2,2-dioxide
4-[(2,4-dioxo-1-[2-oxo-2-(4-toluidino)ethyl]-1,4-dihydro-3(2H)-quinazolinyl)methyl]-N-(3-methoxypropyl)benzamide
1,3-quinazolinediacetamide, 1,2,3,4-tetrahydro-N~1~-(4-methylphenyl)-2,4-dioxo-N~3~-(2-phenylethyl)-
4-[(1-[2-(4-fluoroanilino)-2-oxoethyl]-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]-N-(4-methylbenzyl)benzamide
| Title | Journal or Book | Year |
|---|---|---|
| Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. study of structural requirements for biological activity☆ | Bioorganic & Medicinal Chemistry | 2003 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.